Clinical Trial Update: LV Only MPP With SyncAV [NA]

View source ↗

Summary

Abbott Medical Devices reports the completed clinical trial evaluating left ventricular only multipoint pacing with SyncAV in patients with heart failure and le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Left Bundle Branch Block

Drugs mentioned

• LV Only MPP With SyncAV

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure, Left Bundle-Branch Block | NA | Status: COMPLETED